[go: up one dir, main page]

DK1725569T3 - Product of antiviral agents based on piperazine and substituted piperidine - Google Patents

Product of antiviral agents based on piperazine and substituted piperidine

Info

Publication number
DK1725569T3
DK1725569T3 DK05724510T DK05724510T DK1725569T3 DK 1725569 T3 DK1725569 T3 DK 1725569T3 DK 05724510 T DK05724510 T DK 05724510T DK 05724510 T DK05724510 T DK 05724510T DK 1725569 T3 DK1725569 T3 DK 1725569T3
Authority
DK
Denmark
Prior art keywords
piperazine
product
antiviral agents
agents based
substituted piperidine
Prior art date
Application number
DK05724510T
Other languages
Danish (da)
Inventor
Yasutsugu Ueda
Timothy P Connolly
John F Kadow
Nicholas A Meanwell
Tao Wang
Chung-Pin H Chen
Kap-Sun Yeung
Zhongxing Zhang
David Kenneth Leahy
Shawn K Pack
Nachimuthu Soundararajan
Pierre Sirard
Kathia Levesque
Dominique Thoraval
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963934&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1725569(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK1725569T3 publication Critical patent/DK1725569T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/062—Organo-phosphoranes without P-C bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05724510T 2004-03-15 2005-03-03 Product of antiviral agents based on piperazine and substituted piperidine DK1725569T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55332004P 2004-03-15 2004-03-15
US63523104P 2004-12-10 2004-12-10
PCT/US2005/006980 WO2005090367A1 (en) 2004-03-15 2005-03-03 Prodrugs of piperazine and substituted piperidine antiviral agents

Publications (1)

Publication Number Publication Date
DK1725569T3 true DK1725569T3 (en) 2008-06-02

Family

ID=34963934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05724510T DK1725569T3 (en) 2004-03-15 2005-03-03 Product of antiviral agents based on piperazine and substituted piperidine

Country Status (26)

Country Link
US (12) US7745625B2 (en)
EP (1) EP1725569B1 (en)
JP (1) JP4734318B2 (en)
KR (1) KR101153594B1 (en)
CN (1) CN101941990B (en)
AR (1) AR048039A1 (en)
AT (1) ATE384728T1 (en)
AU (1) AU2005223736C1 (en)
BR (1) BRPI0508876B8 (en)
CA (1) CA2560253C (en)
CY (1) CY1107419T1 (en)
DE (1) DE602005004517T2 (en)
DK (1) DK1725569T3 (en)
ES (1) ES2299022T3 (en)
GE (1) GEP20094736B (en)
HR (1) HRP20080064T5 (en)
IL (1) IL211961A (en)
MY (1) MY139243A (en)
NO (1) NO336742B1 (en)
NZ (2) NZ585294A (en)
PE (1) PE20051151A1 (en)
PL (1) PL1725569T3 (en)
PT (1) PT1725569E (en)
RS (1) RS50567B (en)
TW (1) TWI344843B (en)
WO (1) WO2005090367A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
NZ537752A (en) 2002-07-29 2006-12-22 Rigel Pharmaceuticals Inc Use of 2,4-pyrimidinediamine compounds in the preparation of medicaments for treating autoimmune diseases
US20050075364A1 (en) * 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
JP4886511B2 (en) 2003-07-30 2012-02-29 ライジェル ファーマシューティカルズ， インコーポレイテッド Method for treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US7745625B2 (en) * 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
US7130185B2 (en) * 2004-06-02 2006-10-31 Research In Motion Limited Handheld computing device having drop-resistant LCD display
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
KR101278397B1 (en) 2005-01-19 2013-06-25 리겔 파마슈티칼스, 인크. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
US7723338B2 (en) * 2005-01-31 2010-05-25 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
US7396830B2 (en) 2005-10-04 2008-07-08 Bristol-Myers Squibb Company Piperazine amidines as antiviral agents
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7501419B2 (en) * 2006-04-25 2009-03-10 Bristol-Myers Squibb Company 4-Squarylpiperazine derivatives as antiviral agents
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
US7504399B2 (en) * 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
JP5433691B2 (en) * 2008-06-25 2014-03-05 ブリストル−マイヤーズ スクイブ カンパニー Diketopiperidine derivatives as HIV binding inhibitors
CN102131810B (en) * 2008-06-25 2014-02-26 百时美施贵宝公司 Diketone fused azolopiperidines and azolopiperazines as anti-HIV agents
PL2323633T3 (en) * 2008-09-04 2012-08-31 Viiv Healthcare Uk No 4 Ltd Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
US8399513B2 (en) 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
CN102186804A (en) * 2008-10-20 2011-09-14 克塞诺波特公司 The method for synthesizing levodopa ester prodrug
WO2010151711A1 (en) * 2009-06-25 2010-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds
ES2565644T3 (en) * 2009-11-09 2016-04-06 Xenoport, Inc. Pharmaceutical compositions and oral dosage forms of a levodopa pre-medication and methods of use
MX2012013703A (en) 2010-06-04 2012-12-17 Bristol Myers Squibb Co Modified c-3 betulinic acid derivatives as hiv maturation inhibitors.
MX2012013628A (en) 2010-06-04 2012-12-17 Bristol Myers Squibb Co C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors.
US8450361B2 (en) 2010-08-06 2013-05-28 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
ES2585396T3 (en) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alkylamides as inhibitors of HIV binding
HRP20151212T1 (en) 2011-01-31 2015-12-04 Bristol-Myers Squibb Company C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
PH12013501528A1 (en) 2011-01-31 2013-09-16 Bristol Myers Squibb Co C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
US8436168B2 (en) 2011-01-31 2013-05-07 Bristol-Myers Squibb Company Methods of making HIV attachment inhibitor prodrug compound and intermediates
EP2696937B1 (en) 2011-04-12 2017-05-17 VIIV Healthcare UK (No.5) Limited Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
US8664213B2 (en) 2011-08-29 2014-03-04 Bristol-Myers Squibb Company Spiro bicyclic diamine derivatives as HIV attachment inhibitors
ES2616268T3 (en) 2011-08-29 2017-06-12 VIIV Healthcare UK (No.5) Limited Condensed bicyclic diamine derivatives as inhibitors of HIV binding
CA2849475A1 (en) 2011-09-21 2013-03-28 Bristol-Myers Squibb Company Novel betulinic acid derivatives with antiviral activity
US20140356863A1 (en) 2011-11-21 2014-12-04 Bristol-Myers Squibb Company Methods for determining the susceptibility of a virus to an attachment inhibitor
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
US9248139B2 (en) 2011-12-21 2016-02-02 Bristol-Myers Squibb Company Co-processing method and formulations for HIV attachment inhibitor prodrug compound and excipients
US8889869B2 (en) * 2012-02-08 2014-11-18 Bristol-Myers Squibb Company Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
US8906889B2 (en) 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
US9193725B2 (en) 2012-03-14 2015-11-24 Bristol-Meyers Squibb Company Cyclic hydrazine derivatives as HIV attachment inhibitors
US8889854B2 (en) 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
BR122021020778B1 (en) 2012-06-19 2022-07-12 Debiopharm International Sa PRO-Drug DERIVATIVES OF (E)-N-METHYL-N-((3-METHYLBENZOFURAN-2-YL) METHYL)-3-(7-OXO-5,6,7,8-TETRAHYDRO-1,8- NAFTIRINDIN-3-IL) ACRYLAMIDE
WO2014025854A1 (en) 2012-08-09 2014-02-13 Bristol-Myers Squibb Company Piperidine amide derivatives as hiv attachment inhibitors
ES2616432T3 (en) 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivatives of tricyclic alkenes as inhibitors of HIV binding
CN105121454A (en) 2013-02-06 2015-12-02 百时美施贵宝公司 C-19 modified triterpenoids with HIV maturation inhibitory activity
BR112015019590A2 (en) 2013-02-25 2017-07-18 Bristol Myers Squibb Co c-3 alkyl and alkenyl modified betulinic acid derivatives useful in the treatment of HIV
US20160052923A1 (en) * 2013-03-27 2016-02-25 Bristol-Myers Squibb Company Piperazine and homopiperazine derivatives as hiv attachment inhibitors
PT2978763T (en) * 2013-03-27 2018-04-16 Viiv Healthcare Uk No 5 Ltd 2-keto amide derivatives as hiv attachment inhibitors
MA39374A1 (en) 2014-04-11 2018-06-29 Viiv Healthcare Uk No 4 Ltd Triterpenoids exhibiting hiv maturation inhibition activity, substituted in the 3rd position by a non-aromatic ring bearing a haloalkyl substituent
US9920090B2 (en) 2014-06-19 2018-03-20 VIIV Healthcare UK (No.5) Limited Betulinic acid derivatives with HIV maturation inhibitory activity
EP3218388A1 (en) 2014-11-14 2017-09-20 VIIV Healthcare UK (No.5) Limited C17-aryl substituted betulinic acid analogs
WO2016077561A1 (en) 2014-11-14 2016-05-19 Bristol-Myers Squibb Company Oxolupene derivatives
AU2015364535A1 (en) 2014-12-18 2017-07-06 Viiv Healthcare Uk (No. 4) Limited A process for preparing halogenated azaindole compounds using PyBroP
EP3233853B1 (en) 2014-12-18 2019-03-06 Viiv Healthcare Uk (No. 4) Limited A process for preparing halogenated azaindole compounds using boroxine
WO2016168462A1 (en) 2015-04-14 2016-10-20 Bristol-Myers Squibb Company Crystalline forms of modified triterpenoid hydrochloride salts with hiv maturation inhibitor activity
UA122346C2 (en) 2015-10-01 2020-10-26 Олема Фармасьютикалз, Інк. TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
PT3390412T (en) * 2015-12-14 2021-06-22 Max Planck Gesellschaft Zur Foerderung Der Wss Water-soluble derivatives of 3,5-diphenyl-diazole compounds
US20190030025A1 (en) 2016-02-04 2019-01-31 VIIV Healthcare UK (No.5) Limited Fostemsavir for use in heavily treatment-experienced hiv-1 infected individuals
AR107512A1 (en) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD TRITERPENOIDS MODIFIED IN C-3 AND C-17 AS HIV-1 INHIBITORS
SI3419628T1 (en) 2016-02-26 2021-03-31 Debiopharm International Sa Medicament for treatment of diabetic foot infections
ES2942463T3 (en) 2017-11-21 2023-06-01 Pfizer 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazol-5,4') crystalline salt 2-amino-2-(hydroxymethyl)propane-1,3-diol -piperidine]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoic
ES2972293T3 (en) 2019-01-17 2024-06-12 Viiv Healthcare Uk No 4 Ltd Procedure to prepare fostemsavir
PH12021551922A1 (en) 2019-02-14 2022-05-23 Debiopharm Int Sa Afabicin formulation, method for making the same
UA129222C2 (en) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Afabicin for use for treating bacterial infections involving biofilm
JP7616794B2 (en) 2019-07-07 2025-01-17 オレマ ファーマシューティカルズ インク． Estrogen Receptor Antagonist Regimens
EP4447969A1 (en) 2021-12-17 2024-10-23 VIIV Healthcare Company Combination therapies for hiv infections and uses thereof
AU2023374573A1 (en) 2022-11-02 2025-04-17 VIIV Healthcare UK (No.5) Limited Antigen binding proteins
WO2025229019A1 (en) 2024-04-30 2025-11-06 VIIV Healthcare UK (No.5) Limited Neutralizing antibody constructs against hiv
WO2025229018A1 (en) 2024-04-30 2025-11-06 VIIV Healthcare UK (No.5) Limited Neutralizing antibody constructs against hiv

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5619238A (en) 1992-07-24 1997-04-08 Canon Kabushiki Kaisha Method of making replaceable ink cartridge
US6469006B1 (en) 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
US20020061892A1 (en) 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
AU6872701A (en) * 2000-07-10 2002-01-21 Bristol Myers Squibb Co Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
IL157029A0 (en) * 2001-02-02 2004-02-08 Bristol Myers Squibb Co Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
WO2003082881A2 (en) 2002-03-28 2003-10-09 Procyon Biopharma Inc. Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
US7745625B2 (en) * 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
US7776863B2 (en) 2004-03-24 2010-08-17 Bristol-Myers Squibb Company Methods of treating HIV infection
US7130185B2 (en) * 2004-06-02 2006-10-31 Research In Motion Limited Handheld computing device having drop-resistant LCD display
US7723338B2 (en) * 2005-01-31 2010-05-25 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US8436168B2 (en) * 2011-01-31 2013-05-07 Bristol-Myers Squibb Company Methods of making HIV attachment inhibitor prodrug compound and intermediates
US8889869B2 (en) * 2012-02-08 2014-11-18 Bristol-Myers Squibb Company Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

Also Published As

Publication number Publication date
US20150025240A1 (en) 2015-01-22
NO336742B1 (en) 2015-10-26
DE602005004517D1 (en) 2008-03-13
US20150232414A1 (en) 2015-08-20
US20200046743A1 (en) 2020-02-13
US20100210599A1 (en) 2010-08-19
BRPI0508876A (en) 2007-09-04
WO2005090367A1 (en) 2005-09-29
HRP20080064T3 (en) 2008-03-31
CY1107419T1 (en) 2012-12-19
US8461333B2 (en) 2013-06-11
PT1725569E (en) 2008-03-28
US20190111066A1 (en) 2019-04-18
NZ585294A (en) 2011-09-30
US20210023098A1 (en) 2021-01-28
US8168615B2 (en) 2012-05-01
BRPI0508876B1 (en) 2020-05-26
US20150315218A1 (en) 2015-11-05
AR048039A1 (en) 2006-03-22
US7745625B2 (en) 2010-06-29
RS50567B (en) 2010-05-07
NO20064062L (en) 2006-12-08
CA2560253A1 (en) 2005-09-29
US8871771B2 (en) 2014-10-28
US20180000849A1 (en) 2018-01-04
US20130253196A1 (en) 2013-09-26
KR20060129533A (en) 2006-12-15
JP4734318B2 (en) 2011-07-27
ES2299022T3 (en) 2008-05-16
US20120238755A1 (en) 2012-09-20
ATE384728T1 (en) 2008-02-15
AU2005223736B2 (en) 2011-05-26
EP1725569A1 (en) 2006-11-29
AU2005223736C1 (en) 2011-10-06
HK1148533A1 (en) 2011-09-09
IL211961A (en) 2013-08-29
JP2007529519A (en) 2007-10-25
US20160361328A1 (en) 2016-12-15
GEP20094736B (en) 2009-07-27
PL1725569T3 (en) 2008-09-30
DE602005004517T2 (en) 2009-01-22
TW200600096A (en) 2006-01-01
BRPI0508876B8 (en) 2021-05-25
US20050209246A1 (en) 2005-09-22
CN101941990B (en) 2012-04-25
NZ549867A (en) 2010-07-30
KR101153594B1 (en) 2012-07-05
RU2374256C2 (en) 2009-11-27
CN101941990A (en) 2011-01-12
CA2560253C (en) 2013-01-15
MY139243A (en) 2009-09-30
US11369624B2 (en) 2022-06-28
RU2006136390A (en) 2008-04-27
HK1096687A1 (en) 2007-06-08
AU2005223736A1 (en) 2005-09-29
PE20051151A1 (en) 2006-01-20
TWI344843B (en) 2011-07-11
EP1725569B1 (en) 2008-01-23
HRP20080064T5 (en) 2008-10-31

Similar Documents

Publication Publication Date Title
DK1725569T3 (en) Product of antiviral agents based on piperazine and substituted piperidine
ATE455629T1 (en) RAZORS AND CASSETTES
ATE542648T1 (en) RAZORS AND CASSETTES
DK1472255T3 (en) Aza-aryl piperazines
ATE382611T1 (en) PIPERAZINE WITH OR-SUBSTITUTED PHENYL GROUP AND THEIR USE AS GLYT1 INHIBITORS
DK1515969T3 (en) Spiroindoline piperidine derivatives
DE602005016890D1 (en) CHINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS
DK1527067T3 (en) 4-Trifluoromethylpyrazolyl-substituted pyridines and pyrimidines
EP1788874A4 (en) SALTS OF 5-AZACYTIDINE
DE60302137D1 (en) piperidine
DK1470732T3 (en) PROVISION OF LOCATION INFORMATION
ITBO20040806A1 (en) BURGLAR ENCLOSURE
DK1675852T3 (en) Heterocyclic 7-amino-alkylidenyl-quinolones and naphthyridones
ATE405573T1 (en) AMIDE PRODRUG OF GEMCITABINE, COMPOSITIONS AND USE THEREOF
FI20040261A0 (en) Providing time information
IS7860A (en) Substituted alkyl amido piperidine
DE60336025D1 (en) COLLIMATOR AND PUNCHER
ITBO20040807A1 (en) BURGLAR ENCLOSURE
EP1919479A4 (en) MELANOCORTIN RECEPTOR-SPECIFIC PIPERAZINE AND KETO-PIPERAZINE COMPOUNDS
EP1687398A4 (en) HIV-dependent expression enhancers and uses thereof
EP1723758A4 (en) CROSS-CODING OF INFORMATION IN INDEPENDENT CHANNELS
EP1708704A4 (en) 4-ARYLE PIPERIDINES
ZA200607466B (en) Prodrugs of piperazine and substituted piperidine antiviral agents
ATE349441T1 (en) HALO ALKYL AND PIPERIDINE SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
IL177945A0 (en) Prodrugs of piperazine and substituted piperidine antiviral agents